Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Range [Domain] Statistical Measurement [Domain] Schedule of Fair Value and Amortized Cost Debt Securities, Available-for-Sale [Table Text Block] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Award Timing Predetermined Award Timing Predetermined [Flag] 2026 (remaining 9 months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Related Party Transaction [Axis] Related Party Transaction [Axis] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Other Noncurrent Assets Other Noncurrent Assets [Member] Tabular List, Table Tabular List [Table Text Block] Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Grant award, grantee maximum expected contribution Grant Award, Grantee Maximum Expected Contribution Grant Award, Grantee Maximum Expected Contribution Pfizer Pfizer Inc [Member] Pfizer Inc. Accounts payable Increase (Decrease) in Accounts Payable Certain Executive Officers And Other Employees Certain Executive Officers And Other Employees [Member] Certain Executive Officers And Other Employees Royalties payments Payments for Royalties License License [Member] Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Antion Antion [Member] Antion Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Commercial paper Commercial paper Commercial Paper [Member] Number of shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Co-Manager Agreement Co-Manager Agreement [Member] Co-Manager Agreement Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Restricted stock units, expected to vest (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Number Number of fully vested and expected to vest options outstanding that can be converted into shares under equity instruments other than options. Schedule of Segment Profit or Loss and Segment Expenses Schedule of Segment Reporting Information, by Segment [Table Text Block] Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Equipment impairment Impairment, Long-Lived Asset, Held-For-Use [Member] Impairment, Long-Lived Asset, Held-For-Use Adjustment to Compensation, Amount Adjustment to Compensation Amount Related party transaction service fee increased percentage Related Party Transaction Consulting Fee Percentage Increase Related Party Transaction Consulting Fee Percentage Increase Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Stock options to purchase common stock Share-Based Payment Arrangement, Option [Member] U.S. agency securities U.S. agency securities US Government Corporations and Agencies Securities [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Restricted stock units, vested and unreleased (in shares) Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested Und Unreleased Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested Und Unreleased Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Antidilutive Securities Antidilutive Securities [Axis] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Schedule of Available-for-sale Securities [Table] Debt Securities, Available-for-Sale [Table] Measurement Frequency Measurement Frequency [Axis] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Insider Trading Policies and Procedures [Line Items] Total stock-based compensation Share-Based Payment Arrangement, Expense Research Collaboration And License Agreement Research Collaboration And License Agreement [Member] Research collaboration and license agreement. Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Issuance of common stock from ATM offering, net of commissions and offering costs (in shares) Stock Issued During Period, Shares, New Issues Current assets: Assets, Current [Abstract] Options forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Computer equipment and purchased software Computer Equipment And Purchased Software [Member] Computer equipment and purchased software. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Cover page. Cover [Abstract] Maximum Maximum [Member] Weighted-average exercise price, exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price General and administrative General and Administrative Expense [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Related party transaction monthly service fees increased Related Party Transaction Monthly Consulting Fee Related Party Transaction Monthly Consulting Fee Net unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position Schedule of Future Lease Payments Under Lease Liability Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] 2031 and thereafter Lessee Operating Lease Liability Payments Due After Year Four Lessee Operating Lease Liability Payments Due After Year Four Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Total operating lease liabilities Total Operating lease liability Operating Lease, Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Entity Shell Company Entity Shell Company Other long-term liabilities Other Liabilities, Noncurrent Bellco Bellco Capital LLC [Member] Bellco Capital LLC. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Weighted average remaining vesting life, expected to vest (in years) Share-based Compensation Arrangement By Share-based Payment Awards Other Than Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term Share-based Compensation Arrangement By Share-based Payment Awards Other Than Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Grant award, loan conversion period deadline, anniversary of award Grant Award, Loan Conversion Period Deadline, Anniversary Of Award Grant Award, Loan Conversion Period Deadline, Anniversary Of Award Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Payment Terms [Domain] Payment Terms [Domain] Payment Terms Name Measure Name Restructuring reserve Restructuring Reserve Letter of Credit Letter of Credit [Member] Net amortization/accretion on investment securities Investment Income, Net, Amortization of Discount and Premium Current portion included in accrued and other current liabilities Operating Lease, Liability, Current Proceeds from maturities of investments Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Document Fiscal Period Focus Document Fiscal Period Focus Area of office space (in square feet) Area Of Office Space Area of office. Award Timing Method Award Timing Method [Text Block] Collaboration costs Collaboration Arrangement, Expense Collaboration Arrangement, Expense Furniture and fixtures Furniture and Fixtures [Member] Award Type Award Type [Axis] HQ Lease HQ Lease [Member] HQ Lease Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Investment, Name [Domain] Investment, Name [Domain] Schedule of Restricted Stock Units Activity Under Plan Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol Aggregate intrinsic value, unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Geographical [Domain] Geographical [Domain] Number of patients treated Grant Award, Number Of Patients Treated Under Study Plan Grant Award Clinical Development Number Of Patients Treatment Completed Agreement term (in years) Lessee, Finance Lease, Term of Contract Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Termination payment Lessee, Finance Lease, Payment Upon Contract Termination Lessee, Finance Lease, Payment Upon Contract Termination Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Restricted Stock Unit Restricted stock units outstanding (Excluding vested but unreleased shares, which are included in weighted-average common shares outstanding) Restricted Stock Units (RSUs) [Member] Income Statement Location Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Committed funding remaining Collaboration Agreement, Committed Funding Remaining To Be Paid Collaboration Agreement, Committed Funding Remaining To Be Paid Restructuring costs Restructuring Costs Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Equity method investments Equity Method Investments Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Related Party Related Party [Member] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Weighted-average fair value at date of grant per share, vested and unreleased (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested And Unreleased, Weighted Average Grant Date Fair Value Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Unreleased Weighted Average Grant Date Fair Value PEO PEO [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Non-cash operating activities: Noncash Investing and Financing Items [Abstract] Related party transaction compensation percentage Related Party Transaction Compensation Percentage Related party transaction compensation percentage. UNITED STATES UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock upon exercise of stock options and vesting of RSUs Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Grant award, royalty fee, amount due to other party, multiplier Grant Award, Royalty Fee, Amount Due To Other Party, Multiplier Grant Award, Royalty Fee, Amount Due To Other Party, Multiplier Accumulated Deficit Retained Earnings [Member] Restricted Stock Units (RSUs) With Market Condition Restricted Stock Units (RSUs) With Market Condition [Member] Restricted Stock Units (RSUs) With Market Condition Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents and restricted cash — beginning of period Cash and cash equivalents and restricted cash — end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Sale of Stock Sale of Stock [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Property plant and equipment, gross Property, Plant and Equipment, Gross Cash and cash equivalents and marketable securities Cash, Cash Equivalents, and Short-Term Investments Reduction to royalty rate, percent Collaborative Arrangement, Rights and Obligations, Royalties Payable, Annual Rate, Reduction, Percent Collaborative Arrangement, Rights and Obligations, Royalties Payable, Annual Rate, Reduction, Percent Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Converted to loan, repayment percentage Grant Award, Amount Converted To Loan, Repayment Percentage Grant Award, Amount Converted To Loan, Repayment Percentage Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Financial liabilities Liabilities, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Restricted stock units, Released (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Released In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Released In Period Other income (expenses), net: Other Income and Expenses [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Schedule of Lease Liabilities Liabilities, Lessee [Table Text Block] Liabilities, Lessee Weighted-average remaining contract term, vested and expected to vest (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Equity Investment Basis [Axis] Equity Investment Basis [Axis] Equity Investment Basis Performance-based restricted stock units (in shares) Restricted stock units, unvested, beginning balance (in shares) Restricted stock units, unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Weighted-average fair value at date of grant per share, expected to vest (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price The weighted average fair value of nonvested awards on equity-based plans excluding option plans for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Notch Therapeutics, Inc. Notch Therapeutics, Inc. [Member] Notch Therapeutics, Inc. Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Related Party Transactions [Abstract] Related Party Transactions [Abstract] Preferred stock, par or stated value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Total lease costs Lease, Cost Equity investment Equity Securities, FV-NI Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Lease Costs Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Weighted-average exercise price, vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Money market funds Money Market Funds [Member] Newark, California Newark, California [Member] Newark [Member] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development, Contract to Perform for Others [Table] Equity Components Equity Components [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Description of Business Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Payments Commencing January 2021 Payments Commencing January 2021 [Member] Payments Commencing January 2021 Area of lease (in square feet) Area Of New Office Building Area of new office building. Number of reportable segments Number of Reportable Segments Performance-Based Restricted Stock Units Performance-Based Restricted Stock Units [Member] Performance-Based Restricted Stock Units Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Aggregate potential milestone payable Collaborative Arrangement, Rights And Obligations, Milestone Payable Collaborative Arrangement, Rights And Obligations, Milestone Payable Interest and other income, net Interest and Other Income Supplemental disclosure: Supplemental Cash Flow Information [Abstract] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Aggregate intrinsic value, expected to vest Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Aggregate Intrinsic Value Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Related Party [Domain] Related and Nonrelated Parties [Domain] Total current liabilities Liabilities, Current Over-Allotment Option Over-Allotment Option [Member] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Positions eliminated, percent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Individual: Individual [Axis] Antion Collaboration Agreement Antion Collaboration Agreement [Member] Antion Collaboration Agreement Research and development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Entity [Domain] Entity [Domain] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Accrued and other current liabilities Accrued And Other Liabilities Current Accrued and other current liabilities. Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Subsidiary, ownership percentage, noncontrolling owner Subsidiary, Ownership Percentage, Noncontrolling Owner Entity Interactive Data Current Entity Interactive Data Current Operating lease cost Operating Lease, Cost Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares) Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Aggregate intrinsic value, exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Stock-based Compensation Expense Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Segment Reporting Segment Reporting Disclosure [Text Block] U.S. treasury securities U.S. treasury securities US Treasury Securities [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property, Plant and Equipment, Type Long-Lived Tangible Asset [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Asset Contribution Agreement Asset Contribution Agreement [Member] Asset contribution agreement. Ownership [Domain] Ownership [Domain] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Depreciation and amortization Depreciation, Depletion and Amortization Other long-term assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Milestone payable per indication Collaborative Arrangement, Rights And Obligations, Aggregate Milestone Payments, Per Additional Indication Collaborative Arrangement, Rights And Obligations, Aggregate Milestone Payments, Per Additional Indication Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Committed funding Collaboration Agreement, Committed Funding Collaboration Agreement, Committed Funding All other development costs Research And Development Expense, Other Development Costs Research And Development Expense, Other Development Costs Equity Investment Basis [Domain] Equity Investment Basis [Domain] Equity Investment Basis [Domain] Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Additional area of lease (in square feet) Additional Area of New Office Building Additional Area of New Office Building Financial Instruments Financial Instruments Disclosure [Text Block] Related party transaction monthly payment in arrears Related Party Transaction Monthly Payments In Arrears Related party transaction monthly payments in arrears. Supporting external spend Supporting External Spend Expense Supporting External Spend Expense Segments [Axis] Segments [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Underwriting discount Sale Of Stock, Underwriting Discount Sale Of Stock, Underwriting Discount Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Area of office space (in square feet) Area Of Office Area of office. Balance Sheet Location [Axis] Statement of Financial Position Location, Balance [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Credit Facility [Domain] Credit Facility [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Research and Development [Abstract] Research and Development [Abstract] Entity Address, Address Line One Entity Address, Address Line One Collaboration agreement, term (in years) Collaboration Agreement, Term Collaboration Agreement, Term Research and development Research and Development Expense License and Collaboration Agreement License And Collaboration Agreement [Member] License and collaboration agreement. Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Investment, Name [Axis] Investment, Name [Axis] Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Lease liability, noncurrent Lease liability, noncurrent Operating Lease, Liability, Noncurrent Foresight Diagnostics Collaboration Agreement Foresight Diagnostics Collaboration Agreement [Member] Foresight Diagnostics Collaboration Agreement Consulting Agreements Consulting Agreements [Member] Consulting agreements. Ownership [Axis] Ownership [Axis] Sales Milestone Sales Milestone [Member] Sales milestone member. Grant award, amount Grant Award, Amount Grant Award, Amount Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Other long-term assets Increase (Decrease) in Other Noncurrent Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Payroll Labor and Related Expense Restricted stock units, granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Purchase of investments Payments to Acquire Investments Title of Individual [Domain] Title and Position [Domain] Restricted stock units, forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Facilities & IT-related spend Facilities And IT-Related Expense Facilities And IT-Related Expense Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Financial assets Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Area of operating lease (in square feet) Area Of Operating Lease Area of operating lease. Counterparty Name [Domain] Counterparty Name [Domain] Number of operating segments Number of Operating Segments 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Investments, All Other Investments [Abstract] Investments, All Other Investments [Abstract] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted-average remaining contract term, outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-average fair value at date of grant per share, granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Related Party [Axis] Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Aggregate intrinsic value, beginning balance Aggregate intrinsic value, ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Letter of credit Letters of Credit Outstanding, Amount Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Workforce Reduction Workforce Reduction [Member] Workforce Reduction Sale of Stock Sale of Stock [Axis] Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Equity Award Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Preferred Stock Preferred Stock [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Weighted-average fair value at date of grant per share, beginning balance (in dollars per share) Weighted-average fair value at date of grant per share, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted cash Restricted Cash, Noncurrent Deposit placed in escrow Escrow Deposit Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Expected shares to be purchased under Employee Stock Purchase Plan Employee Stock [Member] Cash equivalents Cash Equivalents, at Carrying Value Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Financial Instruments [Domain] Financial Instruments [Domain] Net unrealized gain (loss) on available-for-sale investments Net unrealized (loss) gain on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Segments [Domain] Segments [Domain] Royalty rate, percent Collaborative Arrangement, Rights and Obligations, Royalties Payable, Annual Rate, Percent Collaborative Arrangement, Rights and Obligations, Royalties Payable, Annual Rate, Percent Income Statement Location Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Balance Sheet Location [Domain] Statement of Financial Position Location, Balance [Domain] Minimum Minimum [Member] Voting Interest Voting Interest [Member] Voting Interest Significant Accounting Policies Changes In Significant Accounting Policies Policy [Policy Text Block] Changes in significant accounting policies. Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment ATM Offering ATM Offering [Member] ATM Offering Company Selected Measure Name Company Selected Measure Name Overland Pharmaceuticals Inc. Overland Pharmaceuticals Inc. [Member] Overland Pharmaceuticals Inc. Pre-Clinical Development Milestone Pre-Clinical Development Milestone [Member] Pre-Clinical Development Milestone [Member] Aggregate intrinsic value, vested and unreleased Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested And Unreleased, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested And Unreleased, Aggregate Intrinsic Value Preferred stock, $0.001 par value: 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares were issued and outstanding as of March 31, 2026 and December 31, 2025 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Proceeds from CIRM award (Note 5) Proceeds From Grant Awards Proceeds From Grant Awards Accrued interest Interest Payable Proceeds from issuance of common stock under the employee stock purchase plan Proceeds from Stock Plans Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.001 par value: 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 244,816,413 and 229,413,523 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Restructuring Plan [Domain] Restructuring Plan [Domain] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Title of Individual [Axis] Title and Position [Axis] Weighted-average number of shares used in computing net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and Contingencies (Notes 6 and 7) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted average remaining vesting life, unvested (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted-average fair value at date of grant per share, forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Number of options to extend lease Number Of Options To Extend Lease Number of options to extend lease. Entity Small Business Entity Small Business Issuance costs Payments of Stock Issuance Costs Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Other operating expenses Other Cost and Expense, Operating Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Ownership percentage Equity Method Investment, Ownership Percentage Underlying Securities Award Underlying Securities Amount Equity Component Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Weighted-average remaining contract term, exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term ATM offering At The Market Offering [Member] At The Market Offering Operating lease liabilities Increase (Decrease) in Operating Lease Liability Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name CALIFORNIA CALIFORNIA Product and Service [Axis] Product and Service [Axis] Proceeds from issuance of common stock from ATM offering, net of commissions and issuance costs Aggregate gross proceeds Proceeds from Issuance of Common Stock Sublease, term of contract (in years) Sublease, term of contract (in months) Lessor, Operating Lease, Term of Contract Laboratory equipment Laboratory Equipment [Member] Laboratory equipment member. Variable lease cost Variable Lease, Cost Collaboration revenue - related party Revenue from Contract with Customer, Excluding Assessed Tax Realized losses on available-for-sale securities Debt Securities, Available-for-Sale, Realized Loss All Individuals All Individuals [Member] Cema-cel Research And Development Expense, Cema-cel Research And Development Expense, Cema-cel Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Number of options, vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Forgone Recovery, Individual Name Total current assets Assets, Current Range [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] South San Francisco Building Two South San Francisco Building Two [Member] South San Francisco Building Two Total cash equivalents and investments Cash Equivalents And Short Term Investments Cash equivalents and short term investments. Proceeds from issuance of common stock upon exercise of stock options Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount License agreement, minimum ownership threshold, percent License Agreement, Minimum Ownership Threshold, Percent License Agreement, Minimum Ownership Threshold, Percent Aggregate milestone payments Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Maximum remaining contractual maturities of available-for-sale securities (in years) Debt Securities, Available-for-Sale, Term Current liabilities: Liabilities, Current [Abstract] Geographical [Axis] Geographical [Axis] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Aggregate intrinsic value, vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Shares sold in offering (in shares) Sale of Stock, Number of Shares Issued in Transaction Earnings Per Share [Abstract] Earnings Per Share [Abstract] Restructuring Plan [Axis] Restructuring Plan [Axis] Total other income (expenses), net Other income (expenses), net Nonoperating Income (Expense) Subsidiary, ownership percentage, parent Subsidiary, Ownership Percentage, Parent South San Francisco, California South San Francisco, California [Member] South San Francisco, California License And Collaboration Agreements License And Collaboration Agreements [Text Block] License and collaboration agreements. 2018 Plan Two Thousand Eighteen Plan [Member] Two thousand eighteen plan. Schedule of Potentially Dilutive Shares Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Short-term investments Short-term investments Debt Securities, Available-for-Sale, Current Less: Present value adjustment Lessee, Operating Lease, Liability, Undiscounted Excess Amount Overland US Overland US [Member] Overland US Number of properties to be subleased Number Of Properties To Be Subleased Number Of Properties To Be Subleased Cellectis Cellectis S A [Member] Cellectis S.A.. Corporate bonds Corporate bonds Corporate Bond Securities [Member] Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair Value, Measurement Frequency Measurement Frequency [Domain] Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Operating lease, extended term (in years) Lessee, Operating Lease, Renewal Term Revenue, remaining performance obligation, variable consideration amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Net cash proceeds Collaboration Agreement, Net Cash Proceeds, Remitted Collaboration Agreement, Net Cash Proceeds, Remitted Net loss Net loss Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Payment Terms [Axis] Payment Terms [Axis] Payment Terms Preferred stock investment payable Collaborative Arrangement, Rights And Obligations, Preferred Stock Investment, Payable Collaborative Arrangement, Rights And Obligations, Preferred Stock Investment, Payable Expiration Date Trading Arrangement Expiration Date Stock issuance, maximum compensation due to third party, percent Stock Issuance, Maximum Compensation Due To Third Party, Percent Stock Issuance, Maximum Compensation Due To Third Party, Percent Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Restructuring Cost [Table] Restructuring Cost [Table] Entity Current Reporting Status Entity Current Reporting Status Operating lease term (in months) Lessee, Operating Lease, Term of Contract Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Aggregate potential milestone payments, remaining obligation Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments Remaining Collaborative Arrangement, Rights And Obligations, Maximum Aggregate Milestone Payments Remaining Loss from operations Operating Income (Loss) Accumulated deficit Retained Earnings (Accumulated Deficit) Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Subsequent Event Type [Domain] Subsequent Event Type [Domain] Sublease Agreement Sublease Agreement [Member] Sublease Agreement [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Regulatory And Sales Milestones Regulatory And Sales Milestones [Member] Regulatory And Sales Milestones Weighted- Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Table] Statement [Table] Other income (expenses), net Other Nonoperating Income (Expense) Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] April 2026 Public Offering April 2026 Public Offering [Member] April 2026 Public Offering Number of unaffiliated company lessees Number Of Lessees, Unaffiliated Company Number Of Lessees, Unaffiliated Company Antidilutive shares excluded from calculation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount University Of Texas M D Anderson Cancer Center University Of Texas MD Anderson Cancer Center [Member] University Of Texas MD Anderson Cancer Center All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Offering price (in dollars per share) Sale of Stock, Price Per Share Accrued interest receivable from available-fore-sale investments Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Milestone payments Milestone Payments Milestone payments. Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prior investment obligation Collaborative Arrangement, Rights And Obligations, Prior Investment Obligation, Amount Collaborative Arrangement, Rights And Obligations, Prior Investment Obligation, Amount Measure: Measure [Axis] TPG Capital BD, LLC TPG Capital BD, LLC [Member] TPG Capital BD, LLC Weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity Under Plan Share-Based Payment Arrangement, Option, Activity [Table Text Block] Long-term investments Long-term investments Debt Securities, Available-for-Sale, Noncurrent Property, Plant and Equipment, Type Long-Lived Tangible Asset [Domain] Financial Assets and Liabilities Subject to Fair Value Measurements on Recurring Basis and Level of Inputs Used in Such Measurements by Major Security Type Fair Value, Assets Measured on Recurring Basis [Table Text Block] Weighted-average number of shares used in computing net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Warrants and rights outstanding Warrants and Rights Outstanding Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Current Accrued and Other Liabilities Current Accrued and Other Liabilities [Member] Current Accrued and Other Liabilities Number of options, exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Related Party Transaction [Domain] Related Party Transaction [Domain] Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Cost of revenue Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Non-cash rent expense Operating Lease, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Operating lease, base rent and security deposit, payment Operating Lease, Base Rent And Security Deposit, Payment Operating Lease, Base Rent And Security Deposit, Payment Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest expense Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Sublease income Operating Lease, Lease Income Milestone payable remaining Collaborative Arrangement, Rights And Obligations, Aggregate Milestone Payments, Per Additional Indication, Remaining Amount Collaborative Arrangement, Rights And Obligations, Aggregate Milestone Payments, Per Additional Indication, Remaining Amount Subsequent Events Subsequent Events [Text Block] Deposit placed in escrow Increase (Decrease) in Deposit Assets Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Options forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Total liabilities Liabilities Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Property and equipment purchases in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Overland Therapeutics (Formerly Known As Allogene Overland) Overland Therapeutics (Formerly Known As Allogene Overland) [Member] Overland Therapeutics (Formerly Known As Allogene Overland) Underwriting discount (in dollars per share) Sale Of Stock, Underwriting Discount Per Share Sale Of Stock, Underwriting Discount Per Share Servier Servier [Member] Servier. Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Significant operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Cash paid for amounts included in the measurement of lease liabilities Payments for Leasing Costs, Commissions, and Tenant Improvements Weighted-average fair value at date of grant per share, Released (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Released In Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Released In Period, Weighted Average Grant Date Fair Value Issuance of common stock from ATM offering, net of commissions and offering costs Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Reportable Segment Reportable Segment [Member] Reportable Segment Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent California Institute For Regenerative Medicine (CIRM) California Institute For Regenerative Medicine (CIRM) [Member] California Institute For Regenerative Medicine (CIRM) Counterparty Name [Axis] Counterparty Name [Axis] Subsequent Event [Line Items] Subsequent Event [Line Items] Common Stock Common Stock [Member] Fair Value Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Net change in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Regulatory Milestone Regulatory Milestone [Member] Regulatory milestone member.